Biopharma’s Positive FDA Meeting Outlines Path Forward for Trial
September 11, 2018 at 04:00 AM EDT
Source: Streetwise Reports 09/11/2018 A ROTH Capital Partners note explained the outcome of the tête-a-tête and its implications. In a Sept. 6 research report, analyst Yasmeen Rahimi with ROTH Capital Partners relayed that Daré Bioscience [...]
